MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with chronic (lasting a long time) hepatitis C virus (hep C): Genotypes (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis

2024年5月17日 · Mavyret (glecaprevir/pibrentasvir) is an oral combination medicine containing fixed doses of two antivirals, glecaprevir, and pibrentasvir, that may be used to treat adults and children 3 years of age and older with hepatitis C.

MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with chronic (lasting a long time) hepatitis C virus (hep C): Genotypes (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis

5 天之前 · MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with chronic (lasting a long time) hepatitis C virus (hep C): Genotypes (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver...

Glecaprevir/pibrentasvir (G/P), sold under the brand names Mavyret and Maviret, is a fixed-dose combination medication used to treat hepatitis C. [4] [5] It contains glecaprevir and pibrentasvir.

2023年6月30日 · Mavyret (glecaprevir and pibrentasvir) is a prescription drug that’s used to treat hepatitis C. Mavyret comes as oral tablets and pellets, which are swallowed.

2023年10月10日 · MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A).

2018年11月15日 · Glecaprevir/pibrentasvir (Mavyret) is a combination of a hepatitis C virus (HCV) NS3/4A protease inhibitor and an HCV NS5A inhibitor. It is labeled for the treatment of chronic HCV genotype...

2024年5月17日 · Glecaprevir/pibrentasvir (Mavyret) is an oral combination medicine containing fixed doses of 2 antivirals, glecaprevir, and pibrentasvir, that may be used to treat adults and children 3 years of age and older with hepatitis C.